MedTrace Logo

Commercially Available Cannabis Products for Immune Support

NCT05944705 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2024-02-29

No results posted yet for this study

Summary

This study will be a prospective observation of the use of commercially available hemp and cannabis products marketed for immune support.

Conditions

Interventions

DIETARY_SUPPLEMENT

Immune Support Supplement

Cannabinoid and co-active emulsion

Sponsors & Collaborators

  • Agronomed LLC

    collaborator UNKNOWN

  • Center For Interventional Pain and Spine

    lead OTHER

Principal Investigators

  • Philip Kim, MD · Center For Interventional Pain and Spine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-11-01
Primary Completion
2024-11-01
Completion
2024-12-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05944705 on ClinicalTrials.gov